<DOC>
	<DOCNO>NCT02180672</DOCNO>
	<brief_summary>This double-blind , randomize control trial evaluate use nasal corticosteroid treatment childhood obstructive sleep apnea syndrome ( OSAS ) . Efficacy , duration action side-effects determine .</brief_summary>
	<brief_title>Steroids Pediatric Apnea Research Kids</brief_title>
	<detailed_description>Several study suggest NCS leukotriene antagonist may effective treatment childhood OSAS . However , study limit factor small size , lack randomization blinding , short-term follow-up , involvement child mild OSAS , and/or lack stratify presence atopy . Therefore , investigator plan randomize controlled trial evaluate efficacy safety NCS v placebo child mild moderate OSAS . The overall hypothesis NCS safe efficacious treatment mild moderate childhood OSAS , particularly child asthma/atopy , require ongoing maintenance therapy .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion Criteria 1 . 510 year age . 2 . Mild moderate OSAS , define obstructive apnea index 120/hr total sleep time obstructive apnea hypopnea index 230/hr total sleep time . 3 . Parentrelated symptom habitual snoring ( &gt; 3 night per week ) 4 . No history adenotonsillectomy . 5 . Parental/guardian permission ( informed consent ) appropriate , child assent Exclusion Criteria 1 . Severe OSAS significant hypoxemia hypercapnia polysomnography , definitive treatment delay ( AHI &gt; 30/hr , 2 % total sleep time SpO2 &lt; 90 % , endtidal PCO2 &gt; 60 mm Hg &gt; 5 minute , pathologic arrhythmia ) . 2 . History recurrent throat infection ( defined American Academy OtolaryngologyHead Neck Surgery Clinical Practice Guidelines For Tonsillectomy ( 7 ) ) past year follow : &gt; 7 episode past year &gt; 5 episodes/year past 2 year &gt; 3 episodes/year past 3 year . 3 . Abnormalities baseline safety screening test , i.e. , DXA scan show spine whole body bone mineral density &lt; 2.0 standard deviation use race specific curve adjustment height Zscore ; morning cortisol &lt; 3 Âµg/dl morning ACTH &lt; 10 pg/ml ; ophthalmologic exam demonstrate cataract ( except &lt; 2 mm anterior polar cataract ) , aphakia ocular abnormality glaucoma , retinal coloboma , intraocular inflammation microphthalmia . 4 . Failure thrive ( weight/height &lt; 5th percentile age gender ) , may secondary OSAS . 5 . Severe obesity ( BMI zscore &gt; 3 ) OSAS likely persist subject . 6 . Previous adenoidectomy unless adenoidal tissue document regrown . 7 . Previous tonsillectomy . 8 . CPAP therapy . 9 . Any NCS use past 3 month NCS use &gt; 2 week past year . 10 . Current immunotherapy daily antihistamine use . 11 . Recent ( past month ) nasal septum ulcer , surgery trauma . 12 . Other major illness asthma , craniofacial anomaly , endocrine neuromuscular disease , past history cancer . This include child condition may worsen OSAS , hypertension diabetes . 13 . Current use ketoconazole potent CYP3A4 inhibitor . 14 . Families plan move area within year . 15 . Subjects speak either English Spanish well enough complete validate neurobehavioral instrument . 16 . Parents/guardians subject , opinion Investigator , may noncompliant study schedule procedure .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Obstructive sleep apnea syndrome</keyword>
	<keyword>OSA</keyword>
	<keyword>sleep apnea</keyword>
	<keyword>nasal steroid</keyword>
	<keyword>corticosteroid</keyword>
</DOC>